Hepatitis is the term used to describe inflammation of the liver, often caused by viral infections, excessive alcohol consumption, certain medications, or exposure to toxins.
Most people experience mild or no symptoms[3B]. The incubation period for different Hepatitis types varies as follows:
The initial phase of Hepatitis is called the acute phase [9B]. The symptoms include [9A], [9C]:
Fever
Jaundice
Muscle Pain
Dark Urine
Joint Pain
Loss of Appetite
Fatigue
Abdominal Pain
The acute phase is not usually dangerous, but in certain cases, it can result in acute liver failure and death. It could also progress to a chronic infection. This is most likely with Hepatitis B and C. As the disease progresses, chronic Hepatitis can lead to [9D], [9E], [9F], [9G]:
Liver Failure
Itching
Confusion
Blood in the faeces or vomit
Most new infections with the Hepatitis viruses are asymptomatic or undiagnosed [10B]. Due to its largely asymptomatic nature, viral Hepatitis is a silent epidemic [10C]; most people are unaware of their infection.
Diagnosis of Hepatitis infection can be done through serological tests to detect antibodies specific to the type of infection. Tests to detect viral RNA and DNA can help in diagnosing active infections and improve outcomes in viral Hepatitis. Its benefits are:[11A]
Prevention is the most effective approach against the disease. Prevention of Hepatitis requires improvements in sanitation, food safety, immunization, blood safety, and reducing the risk of exposure to the virus in health-care settings and in higher-risk populations
The spread of Hepatitis can be reduced by:
Hepatitis screening involves testing of donated blood for antigens and/or antibodies to determine whether the donated blood has presence of viral Hepatitis. Advance screening involves testing for viral DNA or RNA in blood. Globally, however, there are significant variations in the extent to which donated blood is screened. As a result, in many countries, the recipients of blood and blood products remain at an unacceptable risk of acquiring life-threatening infections.
In India, according to the requirements of The Drugs and Cosmetics Act 1940[14], it is mandatory to screen every unit of blood for HBV and HCV (alongside with HIV, syphilis, and malaria) before transfusion, in all licensed blood banks. Screening for Hepatitis C was introduced in 2001[14] and made mandatory across blood banks in India.
2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298630/
3A. https://www.healthline.com/health/hepatitis#types
4. https://www.who.int/news-room/fact-sheets/detail/hepatitis-a
5A. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
5B. https://www.who.int/publications/m/item/vaccine-preventable-diseases-surveillance-standards-hepb
6. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
7. https://www.cdc.gov/hepatitis-d/about/index.html
8. https://www.who.int/news-room/fact-sheets/detail/hepatitis-e
9A. https://www.mayoclinic.org/diseases-conditions/hepatitis-a/symptoms-causes/syc-20367007
9B. https://pubmed.ncbi.nlm.nih.gov/19399811/
9D. https://www.who.int/health-topics/hepatitis/about-hepatitis#tab=tab_1
9E. https://pmc.ncbi.nlm.nih.gov/articles/PMC7862656/
9F. https://pmc.ncbi.nlm.nih.gov/articles/PMC8371503/
9G. https://pmc.ncbi.nlm.nih.gov/articles/PMC7580357/
10A. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389598/
10B. https://www.ncbi.nlm.nih.gov/books/NBK554549/
10C. https://www.emro.who.int/media/news/world-hepatitis-day2013.html
11A. https://pmc.ncbi.nlm.nih.gov/articles/PMC11686541/
11B. https://pmc.ncbi.nlm.nih.gov/articles/PMC11771266/
11C. https://www.sciencedirect.com/science/article/abs/pii/S1246782017300952
12. https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hepatitis/prevention
13. https://www.ncbi.nlm.nih.gov/books/NBK92029/
14. http://www.naco.gov.in/sites/default/files/Drug%20%26%20Cosmetic%20Act%201940_1.pdf